Meeting the challenges of the new K/DOQI guidelines

Slides:



Advertisements
Similar presentations
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Advertisements

Lesley Stevens MD Tufts-New England Medical Center
Feast or Famine: Survival and Chronic Kidney Disease Kerin Worley and Deb Gipson UNC Chapel Hill April, 2004.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Section 1: CKD Epidemiology
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Volume 61, Issue 2, Pages (August 2014)
Assessment and Diagnosis of Renal Dysfunction in the ICU
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Chronic Kidney Disease in Diabetes
Chapter 1: CKD in the General Population
The MDRD Study.
Renal Function Testing
CPR 1.1. Identifying Patients and Initiating Evaluation
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Volume 67, Issue 6, Pages (June 2005)
American Journal of Kidney Diseases 
Peritoneal dialysis American Journal of Kidney Diseases
End-stage renal disease in developing countries
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Management of hypertension in patients with chronic kidney disease
Chapter 1: CKD in the General Population
Metabolic Complications in Elderly Adults With CKD
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
A Decade After the KDOQI CKD Guidelines
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
II. assessment of dyslipidemias
Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.
I. Introduction American Journal of Kidney Diseases
Volume 72, Issue 10, Pages (November 2007)
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration 
Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the.
Acute Kidney Injury and CKD: Chicken or Egg?
J-Shaped Mortality Relationship for Uric Acid in CKD
Guidelines for the Older Adult With CKD
Volume 75, Issue 10, Pages (May 2009)
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.
Appendix 1: methods used for guideline development
A Decade After the KDOQI CKD Guidelines: A Historical Perspective
Geriatrics American Journal of Kidney Diseases
Hypertension After Kidney Transplant
Quiz Page July 2012 American Journal of Kidney Diseases
American Journal of Kidney Diseases
High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative.
Volume 65, Issue 2, Pages (February 2004)
Nephrology: As It Was Then, But Is Not Now
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?  Pantelis A. Sarafidis, Luis.
Prevalence and Severity of Renal Disease in Familial Dysautonomia
American Journal of Kidney Diseases
Evidence and Outcomes in CKD
Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD 
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD 
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Volume 64, Issue 2, Pages (August 2003)
Volume 72, Issue 3, Pages (August 2007)
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
III. Treating dyslipidemias
Rajni Singhal, Janet E. Hux, Shabbir M H Alibhai, Matthew J. Oliver 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
American Journal of Kidney Diseases
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Meeting the challenges of the new K/DOQI guidelines Garabed Eknoyan, MD  American Journal of Kidney Diseases  Volume 41, Pages 3-10 (June 2003) DOI: 10.1016/S0272-6386(03)00371-8

Fig 1 Adjusted first-year patient death rates by treatment modality and year of incidence, 1988 to 1997. Reprinted with permission.3 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 2 Diagram illustrating the relative points in time when problems related to CKD begin to develop. Many relevant health issues in patients with CKD, such as malnutrition, CVD, and anemia, begin to occur in the earliest stages of CKD. Failure to address these issues long before patients present for hemodialysis therapy may greatly increase the risk for adverse outcomes. Abbreviations: CRF, chronic renal failure; CRI, chronic renal insufficiency; PRF, progressive renal failure; RRT, renal replacement therapy; TX, transplant; HD, hemodialysis; PD, peritoneal dialysis; NKF-DOQI, National Kidney Foundation-Dialysis Outcomes Quality Initiative. American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 3 Prevalence of LVH by level of kidney function. LVH is already present in 30% of patients with mild renal insufficiency (creatinine clearance, 50 to 75 mL/min). To convert mL/min to mL/s multiply by 0.01667. Reprinted with permission.5 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 4 Stages in progression of CKD and therapeutic strategies. Reprinted with permission.4 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 5 Correlation of GFR with (A) creatinine clearance and (B) MDRD Study equation. Reprinted with permission.10 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 6 Serum creatinine levels versus GFRs in 171 patients with glomerular disease. Solid circles joined by continuous line represent the hypothetical relationship between GFR and serum creatinine level when creatinine is excreted solely by glomerular filtration. The broken horizontal line represents the upper limit of normal for serum creatinine level in the laboratory that conducted the test (1.4 mg/dL [124 μmol/L]). To convert mg/dL to μmol/L, multiply by 88.4. Reprinted with permission.14 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 7 Prevalence of hypertension stratified according to GFR in the NHANES III population. Abbreviation: SBP, systolic blood pressure.4 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)

Fig 8 Proportion of patients by number of abnormalities (Abn) by level of GFR in the NHANES III population.4 American Journal of Kidney Diseases 2003 41, 3-10DOI: (10.1016/S0272-6386(03)00371-8)